Interleukin (IL)-7 is a potent stimulus for immature T and B cells and, to a lesser extent, mature T ceils. We have inactivated the Ib7 gene in the mouse germline by using gene-targeting techniques to further understand the biology of IL-7. Mutant mice were highly lymphopenic in the peripheral blood and lymphoid organs. Bone marrow B lymphopoiesis was blocked at the transition from pro-B to pre-B cells. Thymic cellularity was reduced 20-fold, but retained normal distribution of CD4 and CD8. Splenic T cellularity was reduced 10-fold. Splenic B cells, also reduced in number, showed an abnormal population of immature B cells in adult animals. The remaining splenic populations of lymphocytes showed normal responsiveness to mitogenie stimuli. These data show that proper T and B cell development is dependent on Ib7. The IL-7-deficient mice are the first example of single cytokine-deficient mice that exhibit severe lymphoid abnormalities.
T
he biological activities of cytokines, as measured by in vitro assays, had long suggested that these molecules would be important for the development and function of lymphocytes in vivo. However, gene inactivation studies of many of these molecules showed that they were dispensable for the development and normal expansion of lymphocytes. Normal numbers of T and B cells were found in mice that contained induced null mutations of I1.-2 (1), IL-4 (2), I1.-6 (3) (Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray, manuscript submitted for publication), Ibl0 (4), IFN receptors (5) , and the common receptor for GM-CSF and II. -5 (5a) . While all of these animals showed varying phenotypes related to the immune system, the absence of severe lymphoid developmental defects was potentially explained by the redundancy of regulatory cytokine signals. Redundancy implies that removal of a single cytokine signal would not be sufficient to inhibit or severely alter lymphoid development. Alternatively, the idea of redundant function may have arisen simply because the cytokine(s) most crucial for lymphoid development and expansion has not yet been examined by gene-targeting criteria.
To investigate this issue in more detail, we have disrupted the I1.-7 gene in mice by standard techniques. Numerous in vitro biological activities of IL-7 have suggested some unique features of this molecule. For example, the stimulation of lymphocytes by IL-7 appears to be more restricted to immature populations (6, 7) compared with many other cytokines, and IL-7 does not always require additional costimulatory agents (8) . Proliferation of early B cells in bone marrow stromal cultures seemed to be dependent on the presence of IL-7 (9). I1.-7 was also shown to be a maintenance and survival factor for thymocytes (10) , an activity unique to this cytokine. Additionally, antibody neutralization experiments predicted that Ib7 plays an important role in B and T cell development in vivo (11, 12) .
The receptors for IL-7 include, at minimum, two subunits, the IL-7Rol chain and the IL-2R'y chain (also referred to as the common y chain) (13) (14) (15) (16) . As is the case with most cytokine-receptor interactions, these two receptor subunits also bind several other ligands. The IL-2R3, chain is necessary for IL-7 binding as well as for IL-2 (17), IL-4 (18, 19) , I1.-9 (20) , and II.-15 binding (21) . Another subunit, IL-7Rot, binds II.-7 and at least one additional cytokine, thymic stromal derived lymphopoietin (TSLP) 1 (22) . The Ib2R3, chain has been shown to be deficient in human X-linked severe combined immunodeficiency (XSCID), which results in profound effects on human lymphoid development and function (14) .
Gene inactivation studies of common receptor subunits are likely to result in cumulative phenotypes. Therefore, in these types of experiments, it is impossible to discern which aspects of the overall phenotype relate to the function of a specific cytokine. Cytokine-deficient mice are necessary for understanding the basic role of ligand molecules, for understanding the potential redundancies in the cytokine network, and for providing the framework on which to interpret potentially more complex phenotypes associated with mice lacking common receptor subunits.
We reasoned that the targeted disruption of Ib7 would allow us to address whether this single cytokine, due to its potentially unique activities, would approximate an XSCIDlike phenotype, or whether the collective elimination of numerous cytokines that interact with the common IL-2Ry chain, or other receptor systems, would be necessary to produce severe effects on the development and expansion of lymphocytes.
Materials and Methods
Gene Targeting. Fig. 1 B) . Hybridization with a neo gene probe was performed to ensure a single integration site (data not shown). The frequency of homologous recombination was I out of 1,166 doubly resistant clones. Appropriately targeted ES cells were injected into C57BL/6 blastocysts. IL-7-/-mice were generated from matings between I1.-7 +/-mice at the expected Mendelian frequency.
To evaluate the inactivation of the IL-7 gene we performed reverse-transcriptase PCR analysis of thymic stromal cell RNA from 2-wk-old mice, using primers at the 5' and 3' end of the eDNA. Hybridization with the eDNA showed that there was no appropriate specific II.-7 message found in IL-7-/-animals ( Fig. 1 C) . B-actin PCK showed equivalent amounts of KNA in each sample (data not shown). The induced mutation was designed to remove two of four o~-helical bundles of the cytokine structure, but also resulted in apparent mKNA instability. Attempts to culture thymic stromal cells to detect Ib7 biological activity were unsuccessful from both IL-
7-/-and IL-7+/+ mice.
Macroscopic Analysis of lL T-/-Mice. ThelL-7-/-mice appeared healthy at birth and developed normally. Both sexes were fertile. In the mutant mice, the thymus and the spleen were reduced in size and weight, and lymph nodes or Peyer's patches were not detected. Histologically, the thymus of the IL-7-/-mice showed cortical and medullary areas and the spleen showed a normal structure with red and white pulp (data not shown).
IL 7-/-Mice Exhibited
Severe Pe@heral Blood and Tissue Lymphopenia. Ib7-mutant animals were tail bled and ex- amined for peripheral WBC counts. Animals were grouped from 5 wk to 14 wk. Fig. 2 A shows a significant decrease in WBC counts in the mutant animals irrespective of their age. All other blood parameters such as red blood cells, platelets, hemoglobin, and hematocrit were in normal ranges. These same samples were used to produce blood smears, and were evaluated for cell types. The reduced WBC in the mutant animals was due to a severe reduction of lymphocytes from an average of 68.2% to 9.5% (Fig. 2 B) . The nonlymphoid cells in these smears gave normal ratios and absolute numbers of monocytes and granulocytes.
The bone marrow, thymus, and spleen were then evalu- ated for cellularity. While Ib7 mutants had normal numbers of bone marrow cells, both thymus and spleen cellularities were reduced to <5 and 15% of controls, respectively (Fig. 3) . Collectively, these data show a strong dependence on IL-7 for proper expansion of lymphoid lineages. The lymphopenic state persisted in mice up to 4 mo of age, and to date, has shown no increase of peripheral lymphocytes. Additionally, this stable phenotype has shown little animal-to-animal variation.
B Lymphopoiesis in the Bone Marrow Was Blocked at the Transition to Pre-B Cells. Hardy et al. (23) have characterized rou-
tine B lymphopoiesis by a series of developmentally regulated cell surface molecules. B cells are classified from most immature (fraction A) to increasingly more mature populations (fractions B-F) using cell surface markers such as B220, IgM, $7, and HSA. We used these general criteria to evaluate the bone marrow development of B cells in the Ib7-mutant mice. Fig. 4 A shows that the mutant animals contained almost no B220+/IgM + bone marrow cells, in contrast to control animals. As these cells represent later stages orb lymphopoiesis in the bone marrow, we used four-color flow cytometry to evaluate the more immature populations contained within the B220+/IgM -fraction. Fig. 4 B shows that, when gated on B220+/IgM -cells, the population of B220 +/IgM-/$7-/HSA + cells was not present, indicating that the transition of fractions B and C to fraction D in mutant animals was blocked. Thus, the transition to the pre-B cell population (fraction D) was severely impaired.
Reduced Thymocyte Numbers Exhibited Normal Composition of Thymic Subsets.
The remaining 5% ofthymocytes in the mutant animals were examined for CD4, CDS, and CD3 expression. Fig. 5 shows that the thymic subpopulations were present in normal ratios, and suggests that proliferation and expansion rather than differentiation were affected by the lack of I1-,7. A minor observation, which was consistent in all mice tested, was a slight increase in the percentage of CD4 +/CD8 + cells in the IL-7-/-animals.
Analysis of Splenic Abnormalities in IL7-/-Mice.
The spleens of mutant animals exhibited a reduction in cellularity (Fig. 3) . As splenocytes represent a collection of cell types, we evaluated the absolute numbers of lymphocytes in this tissue. Based on FACS | staining, we found a severe reduc- tion in absolute numbers of mature splenic B and T cells (Fig.  6 A) . In addition, the relative proportion of B cells was reduced within the spleens of Ib7-defident mice (Fig. 6 B) . Three-color FACS | analysis of spleen cells was performed to determine the phenotype of the remaining lymphocytes. A population of B220 § + mature B cells were present, and at least some of these cells were IgD +, although at a lower percentage than in controls (Fig. 7, A and B) . In addition, a population of B220 +/IgM-cells existed in the mutant animals, which was not found in the control animals, suggesting a significant number of immature B ceUs in the adult spleen. Analysis of the remaining splenic T cell populations showed normal staining patterns of CD4, CD8, and CD3 (data not shown).
Thymocyte and Splenocyte Response to Mitogenic Stimuli. As the IL-7-mutant animals displayed reduced but stable numbers of splenic lymphocytes and thymocytes, we evaluated the response of these cells to LPS, Con A, or Con A plus rIL-2. The B cell response to LPS was reduced if total splenocytes were used. However, as the spleen showed reduced numbers of B cells as well as an additional reduction in the ratio of B (B220+/IgM +) to non-B ceils, we normalized the per- centage shown in Fig. 6 /~ Table 1 A shows that the proliferative response of B cells was similar to controls when the cell population was normalized. T cells in the spleen also gave reduced overall numbers of cells, but a normal ratio of T to non-T cells, so no correction factor was necessary, and Table 1 B shows that the Con A response of splenic T cells was normal. Similarly, the response of the remaining thymocytes to Con A plus rlL-2 was similar for both groups of animals ( Table 1 C) .
Discussion
Gene targeting analysis of cytokine molecules has led to a better understanding of the role of these molecules during immune responses and normal regulation of the immune system. However, a consistent fnding in the cytokine gene disruption literature has been the absence of severe lymphoid defects due to inactivation of a single cytokine gene. One collective interpretation of these experiments would suggest that the normal appearance and expansion of lymphocytes is not critically dependent on any individual cytokine. Another possibility is that cytokines playing a more crucial role in the appearance and expansion of lymphocytes may be as yet uncharacterized, or not yet analyzed by gene-targeting experiments.
The data we have presented in this report would favor the latter of these two possibilities. This report identifies the first single-cytokine gene-defident mouse that exhibits severe lymphoid abnormalities. Inactivation of the IL-7 gene has shown a stable phenotype of severe peripheral blood lymphopenia. This defect can be traced back to abnormal B lymphopoiesis in the bone marrow. The transition between pro-B, fractions B/C (B220+/IgM-/S7+/HSA +) and pre-B, fraction D (B220 +/IgM-/$7-/HSA +) was blocked. According to the B cell development scheme suggested by Hardy et al. (23) , fractions B and C show a strong proliferative response to IL-7, whereas fraction D is unresponsive to Our data indicate that the proliferative response of cells in fractions B and C to IL-7 is not due to IL-7 exclusively. However, the differentiation of fraction B/C to fraction D showed an absolute dependence on IL-7. The peripheral lymphopenia can also be traced to inefficient thymic development where only 5% of normal thymocyte numbers exist. However, the relative ratios of thymic subpopulations were normal, and only overall numbers of cells were reduced. This is consistent with IL-7 being described in vitro as a proliferation and maintenance factor for thymocytes, but not as a differentiation factor (10, 24, 25) .
Further analyses revealed an interesting phenotype of the few remaining lymphocytes. In addition to reduced numbers of B220+/IgM + cells, there was a population of B220+/ IgM-cells, which was not present in control mice. These cells may represent premature migration of B cells from bone marrow to spleen, or alternatively, abnormal splenic B lymphopoiesis. The remaining B220 +/IgM + cells in the mutant animals contained surface IgD + cells, but in lower numbers and percentages. T cell populations in the spleen were also reduced in number, but normal population of cells as analyzed by CD4, CDS, and CD3 were present.
It is useful to compare the phenotype of the mice we describe here to the recent report of IL-7Rol -/-mice (22) . IL-7Rol -/-mice exhibited a similar overall reduction of B cens, but showed a block in B cell development at the transition of pre-pro-B cells (fraction A) to pro-B cells (fraction B). The Ib7-/-mice were inhibited in the transition from B/C to D, which represents a later developmental block. This difference is likely to be due to other cytokines that use the Ib7Rc~ chain, such as TSLP. Paradoxically, treatment of mice with anti-IL-7 antibodies does not fit precisely with this idea (11) . Instead of showing the predicted block equivalent to Ib7-deficient mice, antibody-treated mice appeared to be blocked at a stage similar to the Ib7Ro~-/-mice. Perhaps the antibody treatment is affecting other cytokines that interact through the IL-7Rc~ chain, as it is difficult to imagine that IL-7 neutralization by an antibody could result in a phenotype more severe than in the corresponding gene inactivation study presented here.
In contrast to the stable reduction of thymocytes we reported, Ib7Rcr -/-mice inexplicably showed two different phenotypes in thymic development. One was similar to the IL-7-/-mice and the other was more severe. Although the reason for the variability is unclear, the more severe phenotype is again likely due to other molecules interacting through the Ib7Rc~ chain.
The IL-7-/-mice exhibited similar lymphocyte abnormalities to IL-2R3/-deficient mice (26) , even though this receptor subunit is shared by at least four other cytokines. Neither the gene inactivation of IL-2 (1) or II:4 (2), or the double mutation of IL-2 and IL-4 (27) showed any defects in lymphopoiesis. This indicates that most of the lymphocyte developmental abnormalities seen in an IIr model of murine XSCID are due mainly to IL-7, and not other cytokines that bind to IL-2R'y.
The data shown here indicate that Ib7 is a unique and nonredundant cytokine, in that it is essential for normal lymphocyte development. To date, II:7-deficient mice have demonstrated the most profound effect on lymphoid development in contrast to gene inactivation of other cytokines previously thought to be important for lymphocyte development.
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